Zenicor Medical Systems AB was founded in 2003 and since then, it has grown to become one of Sweden’s leading medtech companies in the fields of remote cardiology diagnostics and stroke prevention.
Zenicor conducts its own product research and development. Several research projects are under way in conjunction with Karolinska Institutet and several other research centres. The aim is to continue to develop solutions that are in the forefront where research and competitiveness are concerned – in Sweden and globally.
Working together with researchers from Karolinska Institutet, Zenicor has developed a unique system, Zenicor-ECG, to detect and diagnose atrial fibrillation and other arrhythmias simply and cost-effectively. The medical benefits and cost-effectiveness of the system have been proven in a large number of research studies. The use of Zenicor-ECG leads to a reduction in the number of stroke cases and lower healthcare costs.
Zenicor-ECG is now established in over 300 clinics in the Nordics, and northern Europe.